What We Do
Every Caedryn mandate sits on the road between a private company and a public listing — as co-sponsor, as sponsor's advisor, or as buy-side advisor in a reverse takeover.
Practice 01
We don't just advise sponsors. We become one.
Caedryn forms and capitalises special purpose acquisition companies together with operating partners, family offices and anchor investors. As co-sponsor we commit at-risk capital, share in the promote, and take day-to-day responsibility for the vehicle — from entity formation and IPO through target search, de-SPAC and post-closing support.
Co-sponsorship changes the economics of advice. Because our capital sits in the sponsor entity beside our partners', every structuring decision — trust size, warrant coverage, extension mechanics, promote vesting — is made the way a principal makes it.
Practice 02
An outsourced deal team for first-time and repeat sponsors.
Raising and running a SPAC is a two-to-three-year operating commitment executed under public-company scrutiny. For sponsor teams who bring the capital and the franchise, Caedryn supplies the machinery: economics, process, regulatory navigation and execution discipline from feasibility study to shareholder vote.
We are particularly focused on the post-2024 environment — smaller trusts, tighter completion windows, earn-out promotes and the SEC's enhanced disclosure regime — where the difference between a fundable vehicle and a stranded one is decided at structuring, not at marketing.
Practice 03
Reverse takeovers reward preparation and punish improvisation.
For operating companies and acquirers pursuing a listing through reverse takeover — into a U.S. shell or an HKEX-listed vehicle — Caedryn acts exclusively on the buy side. We screen shells, verify what "clean" actually means, negotiate structure and valuation, and navigate the seasoning and reverse-takeover rules that determine whether the listing you buy is the listing you keep.
The economics of an RTO are unforgiving of skipped diligence: legacy liabilities, toxic capitalisation tables and exchange-listing ineligibility surface after closing, not before. Our role is to make sure they surface before.